This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Chiorazzi N, Rai KR, Ferrarini M . Chronic lymphocytic leukemia. N Engl J Med 2005; 352: 804–815.
Messmer BT, Messmer D, Allen SL, Kolitz JE, Kudalkar P, Cesar D et al. In vivo measurements document the dynamic cellular kinetics of chronic lymphocytic leukemia B cells. J Clin Invest 2005; 115: 755–764.
Burger JA, Ghia P, Rosenwald A, Caligaris-Cappio F . The microenvironment in mature B-cell malignancies: a target for new treatment strategies. Blood 2009; 114: 3367–3375.
Burger JA, Tsukada N, Burger M, Zvaifler NJ, Dell’Aquila M, Kipps TJ . Blood-derived nurse-like cells protect chronic lymphocytic leukemia B cells from spontaneous apoptosis through stromal cell-derived factor-1. Blood 2000; 96: 2655–2663.
Tsukada N, Burger JA, Zvaifler NJ, Kipps TJ . Distinctive features of ‘nurselike’ cells that differentiate in the context of chronic lymphocytic leukemia. Blood 2002; 99: 1030–1037.
Bürkle A, Niedermeier M, Schmitt-Gräff A, Wierda WG, Keating MJ, Burger JA . Overexpression of the CXCR5 chemokine receptor, and its ligand, CXCL13 in B-cell chronic lymphocytic leukemia. Blood 2007; 110: 3316–3325.
Nishio M, Endo T, Tsukada N, Ohata J, Kitada S, Reed JC et al. Nurselike cells express BAFF and APRIL, which can promote survival of chronic lymphocytic leukemia cells via a paracrine pathway distinct from that of SDF-1alpha. Blood 2005; 106: 1012–1020.
Deaglio S, Vaisitti T, Bergui L, Bonello L, Horenstein AL, Tamagnone L et al. CD38 and CD100 lead a network of surface receptors relaying positive signals for B-CLL growth and survival. Blood 2005; 105: 3042–3050.
Acknowledgements
We would like to acknowledge Martina Seiffert, Danilo Allegra, Angela Philippen, Bettina Klohs, Lars Bullinger, Stefan Fröhling and Claudia Scholl for helpful discussions and Frederic Blond for the bioinformatics support. We would also like to acknowledge the excellent collaboration with Bernd Korn from the German Cancer Research Center core facility Genome and Proteome. This work was supported by funding from DJCLS SP 08/05, DJCLS R 06/13, the Helmholtz Alliance for Systems Biology and the Max-Eder-Nachwuchsgruppenprogramm of the Deutsche Krebshilfe (No. 107239).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies the paper on the Leukemia website
Supplementary information
Rights and permissions
About this article
Cite this article
Bhattacharya, N., Diener, S., Idler, I. et al. Non-malignant B cells and chronic lymphocytic leukemia cells induce a pro-survival phenotype in CD14+ cells from peripheral blood. Leukemia 25, 722–726 (2011). https://doi.org/10.1038/leu.2010.306
Published:
Issue Date:
DOI: https://doi.org/10.1038/leu.2010.306
This article is cited by
-
Targeting B cell receptor signalling in cancer: preclinical and clinical advances
Nature Reviews Cancer (2018)
-
Defective DROSHA processing contributes to downregulation of MiR-15/-16 in chronic lymphocytic leukemia
Leukemia (2014)
-
Selective, novel spleen tyrosine kinase (Syk) inhibitors suppress chronic lymphocytic leukemia B-cell activation and migration
Leukemia (2012)
-
Inhibiting B-Cell Receptor Signaling Pathways in Chronic Lymphocytic Leukemia
Current Hematologic Malignancy Reports (2012)